The Effect of Adalimumab on the Bone Microstructure in Crohn's Disease (CD) Patients

• Status: Terminated
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The investigators will study the effect of Adalimumab on the bone microstructure.

• Trial with medicinal product

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Gerhard Rogler
• Treatments: Adalimumab

Criteria

Inclusion criteria:

• CDAI > 220 und < 450

• Biologika naiv

• CD seit > 6 Monaten

Exclusion criteria:

• other TNF-Blocker

• Steroids > 40 mg

• Malignoma in der Anamnesis